Key Events This Week
13 Jul: New 52-week high at Rs.422
14 Jul: All-time high reached at Rs.480
15 Jul: Valuation shifts to fair amid strong returns
17 Jul: Week closes at Rs.431.50 (-6.19% on day)
Jul 29, 11:57 AM
BSE+NSE Vol: 41.02 k

Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Fermenta Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting evolving market perceptions and sector benchmarks. Despite this, the micro-cap pharmaceutical company continues to outperform the broader market, presenting a nuanced picture for investors assessing its price attractiveness in comparison to peers and historical averages.
Read full news article
13 Jul: New 52-week high at Rs.422
14 Jul: All-time high reached at Rs.480
15 Jul: Valuation shifts to fair amid strong returns
17 Jul: Week closes at Rs.431.50 (-6.19% on day)

Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article
Fermenta Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid a competitive pharmaceutical and biotechnology sector, where the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now align more closely with sector averages, signalling a recalibration of its price attractiveness for investors.
Read full news article
Surging to an intraday peak of Rs 480 on 14 Jul 2026, Fermenta Biotech Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally, driven by a confluence of bullish technical indicators and sustained price momentum, stands out amid a broadly subdued market backdrop.
Read full news article
With a decisive break above Rs 415.7 on 10 Jul 2026, Fermenta Biotech Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to its sector and the broader market.
Read full news article
With a decisive surge to Rs 414.95 on 09 Jul 2026, Fermenta Biotech Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals across multiple timeframes, underscoring the stock’s robust upward trajectory over the past year.
Read full news articleIntimation of investor meeting
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 we enclose herewith photocopy of the newspaper advertisement published pertaining to notice of 74th AGM of the Company (post dispatch of Annual Report).
Cessation of subsidiary being a wholly-owned subsidiary pursuant to Share Subscription Agreement entered on July 20 2026.
No Upcoming Board Meetings
Fermenta Biotech Ltd has declared 75% dividend, ex-date: 05 Aug 26
Fermenta Biotech Ltd has announced 5:5 stock split, ex-date: 08 Aug 18
Fermenta Biotech Ltd has announced 2:1 bonus issue, ex-date: 13 Feb 20
No Rights history available